This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (for example, "cardiac_ion_channel_repolarization#Altered Action Potential and Calcium Handling"). The module is intended for inherited cardiac channelopathies and calcium-handling arrhythmia syndromes including Long QT syndrome, Short QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (RYR2-CPVT), Timothy syndrome, torsade de pointes / short-coupled ventricular fibrillation, and familial sick sinus syndrome. Conforming nodes substitute the specific variant gene and current (e.g. KCNQ1/IKs or KCNH2/IKr loss of function in LQT1/LQT2, SCN5A late sodium current in LQT3, CACNA1C gain of function in Timothy syndrome, RYR2 calcium leak in CPVT, HCN4/SCN5A loss of function in sinus node dysfunction) while preserving the shared causal architecture. Key conformance target: "cardiac_ion_channel_repolarization#Arrhythmogenic Substrate and Triggered Activity".
Cardiac Ion-Channel or Calcium-Handling Variant
trigger
A pathogenic germline variant alters a cardiac ion channel or calcium-handling protein, changing the magnitude, kinetics, or gating of a depolarizing or repolarizing current, or destabilizing sarcoplasmic-reticulum calcium release. Representative genes include the potassium channels KCNQ1 (IKs) and KCNH2 (IKr), the cardiac sodium channel SCN5A, the L-type calcium channel CACNA1C, the ryanodine receptor RYR2, and the pacemaker channel HCN4. The variant is the upstream trigger common to inherited arrhythmia syndromes in structurally normal hearts.
Downstream
-
Altered Action Potential and Calcium Handling
The variant shifts net depolarizing/repolarizing current or sarcoplasmic-reticulum calcium release, changing action potential duration and diastolic calcium in working myocardium.
-
Sinoatrial Node Pacemaker Dysfunction
The same channel/pacemaker machinery, when loss-of-function, depresses sinoatrial automaticity and conduction.
Altered Action Potential and Calcium Handling
central effector
The variant shifts the balance of cardiomyocyte membrane currents and calcium handling. Reduced repolarizing potassium current or persistent late sodium current prolongs action potential duration (long QT physiology); enhanced repolarizing current or reduced inward calcium current shortens it (short QT physiology); ryanodine-receptor calcium leak raises diastolic cytosolic calcium. Each disturbs the action potential and intracellular calcium that couple excitation to contraction.
Used by disorders
RYR2 CPVT
as RYR2 Gain-of-Function Calcium Leak
Timothy Syndrome
as Delayed cardiomyocyte repolarization and ventricular arrhythmia substrate
Downstream
-
Arrhythmogenic Substrate and Triggered Activity
Prolonged action potential favors early afterdepolarizations; diastolic calcium leak drives delayed afterdepolarizations via sodium-calcium exchange, both producing triggered beats.
Arrhythmogenic Substrate and Triggered Activity
amplifier
Disturbed repolarization and calcium handling generate afterdepolarizations: early afterdepolarizations (EADs) arise from oscillations during prolonged plateau, and delayed afterdepolarizations (DADs) arise when sodium-calcium-exchanger current responds to diastolic calcium release. Regional heterogeneity of action potential duration and conduction produces dispersion of repolarization, the tissue-level substrate that allows triggered beats to initiate and sustain reentrant ventricular arrhythmia.
Downstream
-
Ventricular Tachyarrhythmia
Triggered beats arising on a dispersed-repolarization substrate initiate reentrant and polymorphic ventricular tachyarrhythmia.
Ventricular Tachyarrhythmia
effector
Triggered activity and reentry on the arrhythmogenic substrate produce malignant ventricular tachyarrhythmia: torsade de pointes in long QT physiology, polymorphic or bidirectional ventricular tachycardia in catecholaminergic calcium-leak disorders, and ventricular fibrillation in short QT and Brugada physiology. These rhythms abolish effective cardiac output.
Used by disorders
RYR2 CPVT
as Triggered Ventricular Arrhythmia
Downstream
-
Syncope and Sudden Cardiac Death
Sustained ventricular tachyarrhythmia compromises cardiac output, causing syncope and, if unresolved, sudden cardiac death.
Sinoatrial Node Pacemaker Dysfunction
effector
When the variant causes loss of function in pacemaker or conduction currents, the sinoatrial node fails to generate or propagate impulses normally. Reduced funny current (HCN4) or depressed sodium current (SCN5A) in pacemaker and conduction tissue produces sinus bradycardia, sinus pauses/arrest, sinoatrial exit block, and chronotropic incompetence โ the bradyarrhythmic counterpart to the ventricular-tachyarrhythmia branch.
Downstream
-
Syncope and Sudden Cardiac Death
Severe bradyarrhythmia, sinus pauses, or asystole reduce cerebral perfusion, causing syncope and risk of sudden death.
Syncope and Sudden Cardiac Death
outcome
Loss of effective cardiac output โ from ventricular tachyarrhythmia or from severe bradyarrhythmia/asystole โ causes transient cerebral hypoperfusion (syncope) and, when the rhythm does not terminate, sudden cardiac death. These are the shared clinical endpoints of the inherited arrhythmia syndromes, often the presenting or sentinel event.